Register to get unlimited Level 2

Company Announcements

Grant of Share Options

Related Companies

By LSE RNS

RNS Number : 9635T
Clinigen Group plc
18 October 2017
 

18 October 2017

Grant of Share Options

Clinigen Group plc (AIM: CLIN, the "Company"), announces that, on 16 October 2017, the following Directors and PDMR's were granted share options over a total of 94,676 ordinary shares of 0.1 pence each ("Ordinary Shares"), granted under the Clinigen Group Long Term Incentive Plan 2015. The options are nil cost options intended to vest on 16 October 2020 subject to the achievement of certain performance criteria.

Director/PDMR

Number of share options granted

Total number of share options now held

 

Total number of ordinary shares now held

Total number of ordinary shares (excluding share options) as % issued share capital

Shaun Chilton

34,904

274,790

 

312,943

0.27%

Martin Abell

23,996

183,810

 

19,404

0.02%

Steve Glass

17,888

123,725

 

17,360

0.02%

Debra Ainge

17,888

48,518

 

10,254

0.01%

 

 

-Ends-

 

Contact details

 

Clinigen Group plc

Tel: +44 (0) 1283 495010

Shaun Chilton, Group Chief Executive Officer


Martin Abell, Group Chief Financial Officer




Numis Securities Limited

Tel: +44 (0) 20 7260 1000

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Tom Ballard  (Corporate Broking)




RBC Capital Markets - Joint Broker

Tel: +44 (0) 20 7653 4000

  Marcus Jackson / Elliot Thomas / Jack Wood




Instinctif Partners

Tel: +44 (0) 20 7457 2020

Melanie Toyne-Sewell / Alex Shaw

Email: clinigen@instinctif.com

 

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines.

 

For more information, please visit www.clinigengroup.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHMPBMTMBIBBIR

Top of Page